Biopharma Acquisitions Biopharma merger and acquisition value for the second quarter of 2022 reached $25.4bn from 36 transactions, 20 of which had disclosed values. Four M&A transactions hit or exceed
Financings In the fourth quarter of 2011, biopharma start-ups raised a whopping $693 million – 131% more than Q3. This is the most money generated in this sector since we started running this Quarterl
In Vitro Diagnostics ADx NeuroSciences NV Katholieke Universiteit Leuven ADx NeuroSciences gets antibody rights from KU Leuven [Katholieke Universiteit Leuven] (KU Leuven) has licensed biomarker